{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Endocrine+Disorders&page=25", "query": { "condition": "Endocrine Disorders", "page": 25 }, "page_size": 10 }, "pagination": { "page": 25, "page_size": 10, "total_count": 13471, "total_pages": 1348, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Endocrine+Disorders&page=26&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Endocrine+Disorders&page=24&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-10T15:48:30.892Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07192861", "title": "BETA - Pilot Study", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Diabetes (DM)" ], "interventions": [], "intervention_types": [], "sponsor": "4YouandMe", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 28, "start_date": "2025-07-01", "completion_date": "2025-11-30", "has_results": false, "last_update_posted_date": "2025-09-25", "last_synced_at": "2026-11-10T15:48:30.892Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07192861" }, { "nct_id": "NCT00231894", "title": "Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetes", "Schizophrenia", "Insulin Resistance", "Cognitive Impairment" ], "interventions": [ { "name": "Pioglitazone", "type": "DRUG" }, { "name": "Life style diet group", "type": "BEHAVIORAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "OTHER" ], "sponsor": "Nathan Kline Institute for Psychiatric Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 56, "start_date": "2005-05", "completion_date": "2010-01", "has_results": true, "last_update_posted_date": "2017-12-11", "last_synced_at": "2026-11-10T15:48:30.892Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00231894" }, { "nct_id": "NCT00043082", "title": "S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ovarian Cancer", "Peritoneal Cavity Cancer" ], "interventions": [ { "name": "carboplatin", "type": "DRUG" }, { "name": "pegylated liposomal doxorubicin hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "FEMALE", "summary": "18 Years to 120 Years · Female only" }, "enrollment_count": 61, "start_date": "2002-08", "completion_date": "2011-07", "has_results": false, "last_update_posted_date": "2015-10-26", "last_synced_at": "2026-11-10T15:48:30.892Z", "location_count": 91, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 59 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00043082" }, { "nct_id": "NCT05368623", "title": "Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Diabetes", "Diabetic Retinopathy", "Diabetic Macular Edema", "Diabetic Eye Problems" ], "interventions": [ { "name": "Color fundus photograph", "type": "DIAGNOSTIC_TEST" }, { "name": "Optical Coherence Tomography (OCT) of the retina", "type": "DIAGNOSTIC_TEST" }, { "name": "Mydriatic Agent", "type": "DRUG" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "DRUG" ], "sponsor": "RETINA-AI Health, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 1100, "start_date": "2022-11-03", "completion_date": "2023-03-31", "has_results": false, "last_update_posted_date": "2023-10-16", "last_synced_at": "2026-11-10T15:48:30.892Z", "location_count": 3, "location_summary": "Los Angeles, California • Chicago, Illinois • Houston, Texas", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05368623" }, { "nct_id": "NCT06526273", "title": "PILI 'Āina Household", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 2 Diabetes", "Hypertension", "Dyslipidemias", "Overweight and Obesity" ], "interventions": [ { "name": "PILI 'Āina", "type": "BEHAVIORAL" }, { "name": "Control", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "University of Hawaii", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 210, "start_date": "2025-02-12", "completion_date": "2029-02-26", "has_results": false, "last_update_posted_date": "2026-03-04", "last_synced_at": "2026-11-10T15:48:30.892Z", "location_count": 2, "location_summary": "Honolulu, Hawaii • Kapolei, Hawaii", "locations": [ { "city": "Honolulu", "state": "Hawaii" }, { "city": "Kapolei", "state": "Hawaii" } ], "official_url": "https://clinicaltrials.gov/study/NCT06526273" }, { "nct_id": "NCT05588583", "title": "A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Wounds", "Wound of Skin", "Wound Leg", "Wound; Foot", "Diabetic Foot Ulcer", "Venous Leg Ulcer" ], "interventions": [ { "name": "Mepilex Up", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Molnlycke Health Care AB", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 68, "start_date": "2022-10-31", "completion_date": "2024-03", "has_results": false, "last_update_posted_date": "2023-04-20", "last_synced_at": "2026-11-10T15:48:30.892Z", "location_count": 4, "location_summary": "Castro Valley, California • Los Angeles, California • Miami, Florida + 1 more", "locations": [ { "city": "Castro Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05588583" }, { "nct_id": "NCT06710756", "title": "Lead-212 PSV359 Therapy for Patients With Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pancreatic Ductal Adenocarcinoma", "Gastric Cancer", "Esophageal Cancer", "Colorectal Cancer", "Ovarian Cancer", "Head and Neck Cancer", "Sarcoma", "Mesothelioma" ], "interventions": [ { "name": "[203Pb]Pb-PSV359", "type": "DRUG" }, { "name": "[212Pb]Pb-PSV359", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Perspective Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 112, "start_date": "2025-04-28", "completion_date": "2032-05-28", "has_results": false, "last_update_posted_date": "2026-10-28", "last_synced_at": "2026-11-10T15:48:30.892Z", "location_count": 16, "location_summary": "Los Angeles, California • Miami, Florida • Kansas City, Kansas + 11 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06710756" }, { "nct_id": "NCT00664027", "title": "Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Nephropathy" ], "interventions": [ { "name": "RTA 402 (Bardoxolone Methyl)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2008-04-30", "completion_date": "2009-05-31", "has_results": false, "last_update_posted_date": "2025-05-29", "last_synced_at": "2026-11-10T15:48:30.892Z", "location_count": 3, "location_summary": "Houston, Texas • San Antonio, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00664027" }, { "nct_id": "NCT00803569", "title": "Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Fallopian Tube Cancer", "Ovarian Cancer", "Peritoneal Cavity Cancer" ], "interventions": [ { "name": "ALVAC(2)-NY-ESO-1(M)/TRICOM vaccine", "type": "BIOLOGICAL" }, { "name": "Sargramostim", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Ludwig Institute for Cancer Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 13, "start_date": "2008-11-14", "completion_date": "2011-01-24", "has_results": true, "last_update_posted_date": "2023-10-04", "last_synced_at": "2026-11-10T15:48:30.892Z", "location_count": 2, "location_summary": "Buffalo, New York • New York, New York", "locations": [ { "city": "Buffalo", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00803569" }, { "nct_id": "NCT01438554", "title": "Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumors", "Thyroid Cancer", "Soft-tissue Sarcoma", "Cholangiocarcinoma" ], "interventions": [ { "name": "Pazopanib", "type": "DRUG" }, { "name": "GSK1120212", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 89, "start_date": "2011-10", "completion_date": "2018-08", "has_results": false, "last_update_posted_date": "2018-08-29", "last_synced_at": "2026-11-10T15:48:30.892Z", "location_count": 2, "location_summary": "Baltimore, Maryland • Houston, Texas", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01438554" } ] }